diltiazem has been researched along with albuterol in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (30.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Angus, JA; Coe, SA; Kawabata, H; Knight, KR; O'Brien, BM | 1 |
| Bertaccini, G; Coruzzi, G; Poli, E | 1 |
| Bertaccini, G; Coruzzi, G; Montanari, C; Poli, E | 1 |
| Bingham, WT; Duncan, WJ; Kasian, GF; Mersal, A; Ninan, A; Sankaran, K; Tyrrell, MJ | 1 |
| Abel, MH; Hollingsworth, M | 3 |
| Acheson, AG; Scholefield, JH | 1 |
| Corish, J; Corrigan, OI; Fitzpatrick, D; Nolan, LM | 1 |
| Lloyd, HS; Stewart, RAH; Tilyard, MW; Tomlin, AM; Woods, DJ | 1 |
2 review(s) available for diltiazem and albuterol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacological advancements in the treatment of chronic anal fissure.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Albuterol; Botulinum Toxins; Calcium Channel Blockers; Carbachol; Central Nervous System Agents; Cholinergic Agonists; Chronic Disease; Complementary Therapies; Diltiazem; Drug Administration Schedule; Fissure in Ano; Humans; Indoramin; Nitrates; Nitroglycerin; Randomized Controlled Trials as Topic | 2005 |
1 trial(s) available for diltiazem and albuterol
| Article | Year |
|---|---|
Treatment of pulmonary hypertension with diltiazem in a child with bronchopulmonary dysplasia.
Topics: Albuterol; Bronchopulmonary Dysplasia; Child, Preschool; Diltiazem; Humans; Hydralazine; Hypertension, Pulmonary; Infant, Newborn; Isoproterenol; Male; Nifedipine; Oxygen Inhalation Therapy; Pulmonary Heart Disease | 1988 |
17 other study(ies) available for diltiazem and albuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Experience with calcium antagonists nitrendipine, diltiazem, and verapamil and beta 2-agonist salbutamol in salvaging ischemic skin flaps in rabbits.
Topics: Albuterol; Animals; Calcium Channel Blockers; Diltiazem; Injections, Intravenous; Ischemia; Necrosis; Nitrendipine; Rabbits; Reperfusion; Skin; Surgical Flaps; Verapamil | 1991 |
Effect of calcium-channel blockers and salbutamol on the isolated mare uterus--interaction with the calcium agonist Bay K 8644.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Albuterol; Animals; Calcium Channel Blockers; Diltiazem; Drug Interactions; Female; Horses; Nifedipine; Uterine Contraction; Uterus; Verapamil | 1989 |
Pharmacological characterization of mare uterus motility with special reference to calcium antagonists and beta-2-adrenergic stimulants.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Calcium Channel Blockers; Culture Media; Cyclic AMP; Diltiazem; Female; Hexoprenaline; Horses; In Vitro Techniques; Indomethacin; Myometrium; Nifedipine; Tetrodotoxin; Uterine Contraction; Verapamil | 1989 |
Comparison of nifedipine and diltiazem with salbutamol for prevention of preterm delivery in the ovariectomized, oestrogen-treated late pregnant rat.
Topics: Albuterol; Animals; Benzazepines; Diltiazem; Female; Fetal Death; Nifedipine; Obstetric Labor, Premature; Ovariectomy; Pregnancy; Rats; Rats, Inbred Strains; Uterine Contraction | 1986 |
The effects of long-term infusion of salbutamol, diltiazem and nifedipine on uterine contractions in the ovariectomized, post-partum rat.
Topics: Albuterol; Animals; Benzazepines; Diltiazem; Female; Nifedipine; Ovariectomy; Postpartum Period; Pregnancy; Rats; Rats, Inbred Strains; Time Factors; Uterine Contraction | 1986 |
The potencies and selectivities of four calcium antagonists as inhibitors of uterine contractions in the rat in vivo.
Topics: Albuterol; Animals; Blood Pressure; Calcium Channel Blockers; Castration; Diltiazem; Female; Gallopamil; Heart Rate; Nifedipine; Pregnancy; Rats; Rats, Inbred Strains; Uterine Contraction; Verapamil | 1985 |
Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Topics: Administration, Cutaneous; Albuterol; Animals; Chemistry, Pharmaceutical; Diclofenac; Diffusion; Diffusion Chambers, Culture; Diltiazem; Drug Compounding; Drug Delivery Systems; Fatty Acids; Gels; Humans; Iontophoresis; Kinetics; Lauric Acids; Liquid Crystals; Mice; Mice, Hairless; Models, Biological; Nicotine; Oleic Acid; Permeability; Pharmaceutical Preparations; Pharmaceutical Vehicles; Skin; Skin Absorption; Stearic Acids | 2007 |
Understanding medicines with a propensity to increase the risk of heart failure: Combining existing knowledge with targeted population assessment.
Topics: Aged; Aged, 80 and over; Albuterol; Antifungal Agents; Case-Control Studies; Clozapine; Diltiazem; Drug Therapy, Combination; Female; Follow-Up Studies; Health Services Needs and Demand; Heart Failure; Hospitalization; Humans; Indomethacin; Male; Middle Aged; New Zealand; Pioglitazone; Primary Health Care; Propensity Score; Risk Factors | 2018 |